Use of antimicrobials during the COVID-19 pandemic: A qualitative study among stakeholders in Nepal

Author:

Dhungel BinodORCID,Thapa Shrestha UpendraORCID,Adhikari Sanjib,Adhikari NabarajORCID,Bhattarai Alisha,Pokharel SunilORCID,Karkey Abhilasha,Limmathurotsakul Direk,Ghimire Prakash,Rijal Komal RajORCID,Cheah Phaik Yeong,Pell Christopher,Adhikari BipinORCID

Abstract

The COVID-19 pandemic was a major public health threat and the pressure to find curative therapies was tremendous. Particularly in the early critical phase of the pandemic, a lot of empirical treatments, including antimicrobials, were recommended. Drawing on interviews with patients, clinicians and drug dispensers, this article explores the use of antimicrobials for the management of COVID-19 in Nepal. A total of 30 stakeholders (10 clinicians, 10 dispensers and 10 COVID-19 patients) were identified purposively and were approached for an interview. Clinicians and dispensers in three tertiary hospitals in Kathmandu assisted in the recruitment of COVID-19 patients who were undergoing follow-up at an out-patient department. Interviews were audio recorded, translated and transcribed into English, and were analyzed thematically. The respondents report that over-the-counter (OTC) use of antibiotics was widespread during the COVID-19 pandemic in Nepal. This was mostly rooted in patients’ attempts to mitigate the potential severity of respiratory illnesses, and the fear of the stigmatization and social isolation linked to being identified as a COVID-19 patient. Patients who visited drug shops and physicians reportedly requested specific medicines including antibiotics. Clinicians reported uncertainty when treating COVID-19 cases that added pressure to prescribe antimicrobials. Respondents from all stakeholder groups recognized the dangers of excessive use of antimicrobials, with some referring to the development of resistance. The COVID-19 pandemic added pressure to prescribe, dispense and overuse antimicrobials, accentuating the pre-existing OTC use of antimicrobials. Infectious disease outbreaks and epidemics warrant special caution regarding the use of antimicrobials and specific policy response.

Funder

Wellcome Trust

Publisher

Public Library of Science (PLoS)

Reference74 articles.

1. WHO. WHO Coronavirus (COVID-19) Dashboard [May 13, 2023]. Available from: https://covid19.who.int/

2. SARS-CoV-2 vaccines in development;F. Krammer;Nature,2020

3. Projects responding to the COVID-19 pandemic.;GM Winch;Project Leadership and Society,2021

4. The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship.;SH Subramanya;Virusdisease.,2021

5. Antimicrobial resistance: tackling a crisis for the health and wealth of nations.;J. O’neill;Rev Antimicrob Resist.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3